119 related articles for article (PubMed ID: 11788906)
1. Telomerase activity in microdissected human breast cancer tissues: association with p53, p21 and outcome.
Mueller C; Riese U; Kosmehl H; Dahse R; Claussen U; Ernst G
Int J Oncol; 2002 Feb; 20(2):385-90. PubMed ID: 11788906
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of p53, bcl-2 and telomerase activity in Egyptian breast cancer patients.
Swellam M; Ismail M; Eissa S; Hamdy M; Mokhtar N
IUBMB Life; 2004 Aug; 56(8):483-90. PubMed ID: 15545228
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activity in ductal carcinoma in situ and invasive breast cancer.
Umbricht CB; Sherman ME; Dome J; Carey LA; Marks J; Kim N; Sukumar S
Oncogene; 1999 Jun; 18(22):3407-14. PubMed ID: 10362362
[TBL] [Abstract][Full Text] [Related]
5. Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.
Bednarek AK; Sahin A; Brenner AJ; Johnston DA; Aldaz CM
Clin Cancer Res; 1997 Jan; 3(1):11-6. PubMed ID: 9815531
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables.
Kalogeraki A; Kafousi M; Ieromonachou P; Giannikaki E; Vrekoussis T; Zoras O; Tsiftsis D; Stathopoulos E
Anticancer Res; 2005; 25(3B):1927-30. PubMed ID: 16158927
[TBL] [Abstract][Full Text] [Related]
7. [Clinical implications of telomerase activity in breast cancer fine-needle aspirates].
Jin S; Zhang W; Teng M
Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):132-4. PubMed ID: 11776640
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.
Michels JJ; Duigou F; Marnay J; Henry-Amar M; Delozier T; Denoux Y; Chasle J
Cancer; 2003 Mar; 97(6):1376-86. PubMed ID: 12627500
[TBL] [Abstract][Full Text] [Related]
10. [Telomerase activity in infiltration ductal carcinoma of breast].
Wu S; Liu Z; Sun H
Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):515-6. PubMed ID: 10923461
[TBL] [Abstract][Full Text] [Related]
11. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
12. p53 overexpression is a predictor of local recurrence after treatment for both in situ and invasive ductal carcinoma of the breast.
de Roos MA; de Bock GH; de Vries J; van der Vegt B; Wesseling J
J Surg Res; 2007 Jun; 140(1):109-14. PubMed ID: 17291532
[TBL] [Abstract][Full Text] [Related]
13. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
[TBL] [Abstract][Full Text] [Related]
14. The association between telomerase activity and hormone receptor status and p53 expression in breast cancer.
Mokbel K; Ghilchik M; Williams G; Akbar N; Parris C; Newbold R
Int J Surg Investig; 2000; 1(6):509-16. PubMed ID: 11729859
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
[TBL] [Abstract][Full Text] [Related]
16. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer.
Yamashita H; Nishio M; Toyama T; Sugiura H; Zhang Z; Kobayashi S; Iwase H
Breast Cancer Res; 2004; 6(1):R24-30. PubMed ID: 14680497
[TBL] [Abstract][Full Text] [Related]
19. The status of cyclooxygenase-2 expression in ductal carcinoma in situ lesions and invasive breast cancer correlates to cyclooxygenase-2 expression in normal breast tissue.
Leo C; Faber S; Hentschel B; Höckel M; Horn LC
Ann Diagn Pathol; 2006 Dec; 10(6):327-32. PubMed ID: 17126249
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between expressions of telomerase genes and apoptosis related genes in mammary ductal atypical hyperplasia].
Song M; Li BL; Mi XY; Gao YX; Song JY
Ai Zheng; 2002 May; 21(5):484-8. PubMed ID: 12452037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
